Previous Close | 6.20 |
Open | 5.47 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 320.00 |
Expire Date | 2023-04-21 |
Day's Range | 5.47 - 6.25 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
INDIANAPOLIS, IN and SANTA BARBARA, CA / ACCESSWIRE / January 26, 2023 / Direct Relief: Eli Lilly and Company (NYSE:LLY) and Direct Relief today announced a new initiative to expand access to medicines in low- and middle-income countries by boosting ...
The FDA could be just months away from approving Eli Lilly and Boehringer Ingelheim's drug candidate to treat a common condition.
Eli Lilly (NYSE: LLY) is a top healthcare company, and it has generated mild but consistent growth over the years. Has Eli Lilly's stock climbed too quickly and gotten too expensive, or is this still a stock that could go higher? In December, several analysts updated their price targets for Eli Lilly.